MACKENZIE FINANCIAL CORP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$163,000
-47.4%
58,257
+7.3%
0.00%
Q1 2022$310,000
-37.2%
54,282
+0.3%
0.00%
-100.0%
Q4 2021$494,000
+52.9%
54,135
+79.0%
0.00%
Q3 2021$323,000
-31.7%
30,238
-0.7%
0.00%
-100.0%
Q2 2021$473,000
+19.4%
30,466
+24.7%
0.00%0.0%
Q1 2021$396,000
-26.7%
24,426
-4.2%
0.00%0.0%
Q4 2020$540,000
+155.9%
25,510
+184.7%
0.00%0.0%
Q4 2019$211,0008,9600.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders